Alcista
$0.73
Precio del escenario
$2.090
+0.105 (+5.03%)Al cierre
So-Young International Inc is a holding company mainly engaged in online platform for discovering, evaluating and reserving medical aesthetic services. The Company operates its businesses through two segments including So-Young segment and Wuhan Miracle segment. So-Young segment mainly provides information services, reservation services, aesthetic treatment services and sales of medical products and maintenance services. Wuhan Miracle segment is mainly engaged in the research and development, production, sales and agency of laser and other optoelectronic medical equipment. The Company operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website.
So-Young International Inc is not a good buy right now due to its current price of 1.99, which is significantly below its 52-week high of 4.75, and an RSI of 12.45 indicating it is oversold. While the company has shown revenue growth, with Q2 2026 revenue at 505.2 million CNY, a 33% year-over-year increase, it still faces significant net losses, with a net income of -22.7 million CNY in Q2 2026. The main risk is its negative earnings per share of -0.29, which reflects ongoing financial challenges despite some positive revenue trends.
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

So-Young International Reports Record Q2 Revenue Growth

So-Young International Reports Strong Q2 2026 Financial Results

So-Young International Reports Strong Q2 2026 Financial Results

So-Young International to Report Q2 2026 Financial Results

So-Young International Appoints New CFO
So-Young International Inc is a holding company mainly engaged in online platform for discovering, evaluating and reserving medical aesthetic services. The Company operates its businesses through two segments including So-Young segment and Wuhan Miracle segment. So-Young segment mainly provides information services, reservation services, aesthetic treatment services and sales of medical products and maintenance services. Wuhan Miracle segment is mainly engaged in the research and development, production, sales and agency of laser and other optoelectronic medical equipment. The Company operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website. It operates in the Consumer Cyclicals sector (COMPUTER PROCESSING AND DATA PREPARATION AND PROCE industry).
So-Young International Inc is not a good buy right now due to its current price of 1.99, which is significantly below its 52-week high of 4.75, and an RSI of 12.45 indicating it is oversold. While the company has shown revenue growth, with Q2 2026 revenue at 505.2 million CNY, a 33% year-over-year increase, it still faces significant net losses, with a net income of -22.7 million CNY in Q2 2026. The main risk is its negative earnings per share of -0.29, which reflects ongoing financial challenges despite some positive revenue trends.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.